FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of formula (I-A) or (I-B):
or ,
as well as to pharmaceutical compositions, containing said compounds.
EFFECT: technical result is obtaining new compounds, suitable for use in the prevention or treatment of a disease or condition mediated by an FGFR kinase, for example cancer.
21 cl, 1 tbl, 43 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF 1,5- AND 1,7-NAPHTHYRIDINE USEFUL IN TREATMENT OF FGFR-MEDIATED DISEASES | 2012 |
|
RU2629194C2 |
| QUINAZOLINONE DERIVATIVES APPLICABLE AS MODULATORS OF FGFR KINASE | 2014 |
|
RU2701517C2 |
| QUINOLINES AS FGFR KINASE MODULATORS | 2012 |
|
RU2625303C2 |
| PTERIDINES AS FGFR INHIBITORS | 2013 |
|
RU2702906C2 |
| ANTI-CANCER BENZOPYRAZINES ACTING THROUGH FGFR-KINASES INHIBITION | 2012 |
|
RU2639863C2 |
| SUBSTITUTED QUINAZINE DERIVATIVES AS FGFR-KINASE INHIBITORS FOR TREATMENT OF CANCER | 2011 |
|
RU2602233C2 |
| COMPOUNDS BASED ON PYRAZOLOPYRIDINONE | 2018 |
|
RU2806751C2 |
| NEW QUINOLINE COMPOUNDS | 2018 |
|
RU2810113C2 |
| COMPOUNDS BASED ON PYRAZOLOPYRIDINONE | 2018 |
|
RU2806625C2 |
| AMINOBENZIMIDAZOLE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION | 2004 |
|
RU2332414C2 |
